The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Clexane 4,000 IU (40mg) /0.4 mL Solution for Injection in pre-filled syringes

40 milligram(s) Solution for injection in pre-filled syringe

Sanofi-Aventis Ireland Limited T/A SANOFIPA0540/097/005

Main Information

Trade NameClexane 4,000 IU (40mg) /0.4 mL Solution for Injection in pre-filled syringes
Active SubstancesEnoxaparin sodium
Strength40 milligram(s)
Dosage FormSolution for injection in pre-filled syringe
Licence HolderSanofi-Aventis Ireland Limited T/A SANOFI
Licence NumberPA0540/097/005

Group Information

ATC CodeB01AB Heparin group
B01AB05 enoxaparin


Licence Issued14/07/2017
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back